Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment is a research paper published in Journal for ImmunoTherapy of Cancer (2021). On theSindex it has a DataRank of 1.6. It has been cited 56 times, with 51 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.606
From this paper's citation signal
Citation Network Contribution
0.996
From 42 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 51 citers.
National Institutes of Health
Grant: T32 CA009666
National Institutes of Health
Grant: 5T32CA009666-08
TRAINING FOR ACADEMIC ONCOLOGY
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: P50 CA140388
FWCI
3.41
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy
Additional file 2 of A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy